Cd4+Cd25+ regulatory T cells and their therapeutic potential
- PMID: 16409156
- DOI: 10.1146/annurev.med.57.121304.131337
Cd4+Cd25+ regulatory T cells and their therapeutic potential
Abstract
The human immune system mounts specific responses to a vast array of antigens. Although this is clearly beneficial in fighting off harmful infections and cancerous cells, the system must be carefully controlled to ensure that normal self-antigens are not targeted. A recently characterized subset of T cells, identified by their cell surface expression of CD4 and CD25, is critical in regulating the function of other immune cells and preventing potentially harmful autoimmune responses. This article reviews what is currently known about these so-called regulatory T cells and discusses the therapeutic potential of these cells to modulate human immune-based diseases.
Similar articles
-
Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease.Semin Immunol. 2004 Apr;16(2):135-43. doi: 10.1016/j.smim.2003.12.009. Semin Immunol. 2004. PMID: 15036237 Review.
-
Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.J Immunol. 1995 Aug 1;155(3):1151-64. J Immunol. 1995. PMID: 7636184
-
Natural and induced T CD4+CD25+FOXP3+ regulatory T cells.Methods Mol Biol. 2011;677:3-13. doi: 10.1007/978-1-60761-869-0_1. Methods Mol Biol. 2011. PMID: 20941599
-
The battle to tame autoimmunity.Nature. 2018 Mar 8;555(7695):S8-S9. doi: 10.1038/d41586-018-02476-2. Nature. 2018. PMID: 29517011 No abstract available.
-
[CD4+, CD25+ regulatory T-lymphocytes: current concepts and therapeutic potential].J Soc Biol. 2002;196(4):263-6. J Soc Biol. 2002. PMID: 12645292 Review. French.
Cited by
-
Regulatory T cells and their prognostic value for patients with squamous cell carcinoma of the head and neck.J Cell Mol Med. 2010 Jan;14(1-2):426-33. doi: 10.1111/j.1582-4934.2008.00650.x. Epub 2009 Jan 14. J Cell Mol Med. 2010. PMID: 19183242 Free PMC article.
-
The Molecular and Cellular Mechanisms Associated with a Microvascular Inflammation in the Pathogenesis of Heart Failure with Preserved Ejection Fraction.Acta Naturae. 2020 Apr-Jun;12(2):40-51. doi: 10.32607/actanaturae.10990. Acta Naturae. 2020. PMID: 32742726 Free PMC article.
-
The plasticity of human Treg and Th17 cells and its role in autoimmunity.Semin Immunol. 2013 Nov 15;25(4):305-12. doi: 10.1016/j.smim.2013.10.009. Epub 2013 Nov 5. Semin Immunol. 2013. PMID: 24211039 Free PMC article. Review.
-
Role of denileukin diftitox in the treatment of persistent or recurrent cutaneous T-cell lymphoma.Cancer Manag Res. 2010 Feb 5;2:53-9. doi: 10.2147/cmar.s5009. Cancer Manag Res. 2010. PMID: 21188096 Free PMC article.
-
A new hope in immunotherapy for malignant gliomas: adoptive T cell transfer therapy.J Immunol Res. 2014;2014:326545. doi: 10.1155/2014/326545. Epub 2014 Jun 9. J Immunol Res. 2014. PMID: 25009822 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials